Head-To-Head Review: Bellatrix Exploration (BXEFF) versus Its Rivals

Share on StockTwits

Bellatrix Exploration (OTCMKTS: BXEFF) is one of 176 public companies in the “Crude petroleum & natural gas” industry, but how does it contrast to its competitors? We will compare Bellatrix Exploration to related businesses based on the strength of its analyst recommendations, earnings, valuation, risk, profitability, dividends and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Bellatrix Exploration and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bellatrix Exploration 0 0 0 0 N/A
Bellatrix Exploration Competitors 1987 8192 11829 388 2.47

As a group, “Crude petroleum & natural gas” companies have a potential upside of 43.04%. Given Bellatrix Exploration’s competitors higher possible upside, analysts clearly believe Bellatrix Exploration has less favorable growth aspects than its competitors.

Valuation and Earnings

This table compares Bellatrix Exploration and its competitors revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Bellatrix Exploration $176.47 million -$112.91 million -0.17
Bellatrix Exploration Competitors $10.74 billion $706.73 million 11.91

Bellatrix Exploration’s competitors have higher revenue and earnings than Bellatrix Exploration. Bellatrix Exploration is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

Bellatrix Exploration has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500. Comparatively, Bellatrix Exploration’s competitors have a beta of 1.41, indicating that their average stock price is 41% more volatile than the S&P 500.

Insider and Institutional Ownership

10.8% of Bellatrix Exploration shares are held by institutional investors. Comparatively, 59.6% of shares of all “Crude petroleum & natural gas” companies are held by institutional investors. 10.5% of shares of all “Crude petroleum & natural gas” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Bellatrix Exploration and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bellatrix Exploration -64.23% -19.75% -11.17%
Bellatrix Exploration Competitors -7.61% -15.29% 4.96%

Summary

Bellatrix Exploration competitors beat Bellatrix Exploration on 10 of the 10 factors compared.

Bellatrix Exploration Company Profile

Bellatrix Exploration Ltd., an oil and gas company, engages in the acquisition, exploration, development, and production of oil and natural gas reserves in the provinces of Alberta, British Columbia, and Saskatchewan in Canada. It primarily focuses on developing its two core resource plays, the Cardium and the Spirit River in Western Canada. The company was founded in 2000 and is headquartered in Calgary, Canada.

Receive News & Ratings for Bellatrix Exploration Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellatrix Exploration and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

VeriME Market Cap Tops $374,353.00
VeriME Market Cap Tops $374,353.00
Molina Healthcare, Inc.  Receives Average Rating of “Hold” from Analysts
Molina Healthcare, Inc. Receives Average Rating of “Hold” from Analysts
SPINDLE  Reaches Market Capitalization of $2.12 Million
SPINDLE Reaches Market Capitalization of $2.12 Million
MediBit Trading 32.3% Higher  Over Last 7 Days
MediBit Trading 32.3% Higher Over Last 7 Days
Clovis Oncology  Expected to Announce Earnings of -$1.80 Per Share
Clovis Oncology Expected to Announce Earnings of -$1.80 Per Share
BUDDY Price Down 36.7% Over Last 7 Days
BUDDY Price Down 36.7% Over Last 7 Days


 
© 2006-2019 Zolmax.